Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling

JAMA

Volumn 275, Issue 16, 1996, Pages 1247-1251

  Fiscella, Kevin ^a   Franks, Peter ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; QUALITY OF LIFE; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0029986831     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.16.1247     Document Type: Article

References (53)

1. Centers for Disease Control. Reducing The Health Consequences of Smoking: 25 years of progress - A Report, of the Surgeon General Rockville, Md: US Dept Health and Human Services, Public Health Service; 1989. CDC publication 89-3411.
2. Jamrozik K, Vessey M, Fowler G, et al. Controlled trial of three different antismoking interventions in general practice. BMJ. 1984;288: 1499-1502.
3. Russell MA, Wilson C, Taylor C, Baker CD. Effect of general practitioners' advice against smoking. BMJ. 1979;2:231-235.
4. Stewart PJ, Rosser WW. The impact of routine advice on smoking cessation from family physicians. Can Med Assoc J. 1982;126:1051-1054.
5. Russell MA, Merriman E, Stapleton J, Taylor W. Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. BMJ. 1983;287:1782-1785.
6. Fagerstrom KO. A comparison of psychological and pharmacological treatment in smoking cessation. J Behav Med. 1982;5:343-351.
7. Fee WM, Stewart MJ. A controlled trial of nicotine chewing gum in a smoking withdrawal clinic. Practitioner. 1982;26:148-151.
8. Hjalmarson AI. Effect of nicotine chewing gum in smoking cessation: a randomized, placebo-controlled, double-blind study. JAMA. 1984;252:835-2838.
9. Jarvik ME, Sehneider NG. Degree of addiction and effectiveness of nicotine gum therapy for smoking. Am J Psychiatry. 1984;141:790-791.
10. Jarvis MJ, Raw M, Russell MA, Feyerabend C. Randomized controlled trial of nicotine chewing-gum. BMJ. 1982;285:537-540.
11. Abelin T, Buehler A, Muller P, Vesanen K, Imhof PR. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet. 1989;1:7-10.
12. Abelin T, Ehrsam R, Buhler-Reichert A, et al. Effectiveness of a transdermal nicotine system in smoking cessation studies. Methods Find Exp Clin Pharmacol. 1989;11:205-214.
13. Buchkremer G, Bents H, Horstmann M, Opitz K, Tolle R. Combination of behavioral smoking cessation with transdermal nicotine substitution. Addict Behav. 1989;14:229-238.
14. Hurt RD, Dale LC, Fredrickson PA, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: one-year outcome and percentage of nicotine replacement. JAMA. 1994;271:595-600.
15. Stapleton JA, Russell MA, Feyerabend C, et al. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction. 1995;90:31-42.
16. Sachs DP, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med. 1993;153:1881-1890.
17. Tonnesen P, Norregaard J, Simonsen K, Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med. 1991;325:311-315.
18. Cummings SR, Rubin SM, Oster G. The cost-effectiveness of counseling smokers to quit. JAMA. 1989;261:75-79.
19. Oster G, Huse DM, Delea TE, Colditz GA. Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking. JAMA. 1986;56:1315-1318.
20. Johnson RE, Stevens VJ, Hollis JP, Woodson GT. Nicotine chewing gum use in the outpatient care setting. J Fam Pract. 1992;34:61-65.
21. Lam W, Sze PC, Sacks HS, Chalmers TC. Metaanalysis of randomized controlled trials of nicotine chewing-gum. Lancet. 1987;2:27-30.
22. Benito-Cepeda A. Meta-analytical review of the efficacy of nicotine chewing gum in smoking treatment programs. J Consult Clin Psychol. 1993;61: 822-830.
23. Schauffler HH, Parkinson MD. Health insurance coverage for smoking cessation services. Health Educ Q. 1993;20:185-206.
24. Use of nicotine to stop smoking. Med Lett Drugs Ther. 1995;37:6-8.
25. Tang JL, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ. 1994;308:21-26.
26. Silagy C, Mant D, Fowler G, Lodge M. Metaanalysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;43:139-142.
27. Cummings KM, Biernbaum RM, Zevon MA, Deloughry T, Jaen CR. Use and effectiveness of transdermal nicotine in primary care settings. Arch Fam Med. 1994;3:682-689.
28. Orleans CT, Resch N, Nool E, et al. Use of transdermal nicotine in a state-level prescription plan for the elderly: a first look at 'real-world' patch users. JAMA. 1994;271:601-607.
29. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med. 1995;155:1933-1941.
30. Centers for Disease Control. The Health Benefits of Smoking Cessation: A Report of the Surgeon General Rockville, Md: US Dept of Health and Human Services; 1990.
31. Blondal T. Controlled trial of nicotine polacrilex gum with supportive measures. Arch Intern Med. 1989;149:1818-1821.
32. Centers for Disease Control and Prevention. Smoking cessation during previous year among adults-United States, 1990 and 1991. MMWR Morb Mortal Wkly Rep. 1993;42:504-507.
33. Rogers RG, Powell-Griner E. Life expectancies of cigarette smokers and nonsmokers in the United States. Soc Sci Med. 1991;32:1151-1159.
34. Centers for Disease Control and Prevention. Years of healthy life. Stat Notes. April 1995;7:1-14.
35. Adams PF, Benson V. Current estimates from the National Health Interview Survey, 1991. Vital Health Stat 10. 1992;No. 184.
36. Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes New York, NY: Oxford University Press Inc; 1987.
37. Gold MR, Franks P, McCoy K. Condition weights for chronic diseases from a nationally representative sample. Med Decis Making. 1994;14:431. Abstract.
38. Fiore MC, Jorenby DE, Baker TB, Kenford SL. Tobacco dependence and the nicotine patch: clinical guidelines for effective use. JAMA. 1992;268:2687-2694.
39. TreeAge Software Inc. DATA, Version 2.6. Boston, Mass: TreeAge Software Inc; 1995.
40. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press Inc 1996.
41. Fiore MC, Smith SS, Jorenby JDE, Baker TB. The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA 1994;271:1940-1947.
42. Leu RE, Schaub T. Does smoking increase medical care expenditure? Soc Sci Med. 1983;17:1907-1914.
43. Leu RE, Schaub T. More on the impact of smoking on medical care expenditures. Soc Sci Med. 1985; 21:825-827.
44. Oster G, Colditz GA, Kelly NL. The economic costs of smoking and benefits of quitting for individual smokers. Prev Med. 1984;13:377-389.
45. Manning WG, Keeler EB, Newhouse JP, Sloss EM, Wasserman J. The Costs of Poor Health Hab-its: A Rand Study. Cambridge, Mass: Harvard University Press; 1991.
46. Hodgson TA. Cigarette smoking and lifetime medical expenditures. Milbank Q. 1992;70:81-125.
47. Littenberg B, Garber MD, Sox HC. Screening for hypertension. Ann Intern Med. 1990;112:192-202.
48. Sachs DPL. Effectiveness of the 4-mg dose of nicotine polycruex for the initial treatment of high-dependent smokers. Arch Intern Med. 1995;155: 1973-1980.
49. Hughes JR, Wadland WC, Fenwiek JW, Lewis J, Bickel WK. Effect of cost on the self-administration and efficacy of nicotine gum a preliminary study. Prev Med. 1991; 20:486-496.
50. Pierce JP, Gilpin E, Parkas AJ. Nicotine patch use in the general population: results from the 1993 California tobacco survey. J Natl Cancer Inst. 1995; 87:87-93.
51. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation: who will quit with and without the nicotine patch. JAMA. 1994;271:589-594.
52. Norregaard J, Tonnesen P, Petersen L. Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches. Prev Med. 1993;22:61-271.
53. Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ. Prospective study of factors predicting outcome of transdermal nicotine treatments in smoking cessation. BMJ. 1994;309:842-846.